nan-101
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 20, 2019 (NCT04179643)
Timeline
Indications
Mechanism of action
PPP1CA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05598333 | Phase 2 | Dec 31, 2022 | Asklepion |
| NCT04179643 | Phase 1 | Nov 20, 2019 | Asklepion |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asklepion | For profit | 2 | 2 | 2 | 2019 |
1 organizations
Page 1 / 1